-transparent.png){kind=logo}
A study carried out on 2,006 Tunisian blood donors permitted us to evaluate the prevalence of hepatitis C virus antibodies (anti-HCV) which was 1.09%; frequency of indirect markers of NANBH were as follows: ALAT greater than 2 N (1.24%), anti-HBc (30.35%), 55.5% of HCV (+) donors had anti-HBc (+), 12.5% had rises ALAT and only 33.3% both markers.
Related Publications
H Slama, and
N Mojaat, and
R Dahri, and
K Boukef
January 1997,
Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine,
H Slama, and
N Mojaat, and
R Dahri, and
K Boukef
January 1995,
Vox sanguinis,
H Slama, and
N Mojaat, and
R Dahri, and
K Boukef
November 1994,
Medicina clinica,
H Slama, and
N Mojaat, and
R Dahri, and
K Boukef
October 1992,
Schweizerische medizinische Wochenschrift,
H Slama, and
N Mojaat, and
R Dahri, and
K Boukef
January 2013,
The Indian journal of medical research,
H Slama, and
N Mojaat, and
R Dahri, and
K Boukef
January 1996,
Vox sanguinis,
H Slama, and
N Mojaat, and
R Dahri, and
K Boukef
April 1995,
Vnitrni lekarstvi,
H Slama, and
N Mojaat, and
R Dahri, and
K Boukef
January 2008,
Kathmandu University medical journal (KUMJ),
H Slama, and
N Mojaat, and
R Dahri, and
K Boukef
January 1991,
Beitrage zur Infusionstherapie = Contributions to infusion therapy,
H Slama, and
N Mojaat, and
R Dahri, and
K Boukef
January 2001,
Archives of medical research,
